Business & Industry
Business & Industry
India, Switzerland Discuss Pharma and Biotech Collaboration
Piyush Goyal, the Commerce and Industry Minister, met Helene Budliger Artieda, the visiting Swiss State Secretary for Economic Affairs, and discussed cooperation when it comes to research and development as well as pharma and biotech collaboration with a view...
Business & Industry
Algeria Showcases its Strength in African Pharma Sector
Abdelmadjid Tebboune, the Algerian president, went on to address participants at the African Ministerial Conference on Local Pharmaceutical Production and Health Technologies on November 27, 2025, with his message being read by Sifi Ghrieb, the prime minister.
The event, which...
Business & Industry
Eli Lilly Becomes the First Drugmaker to Hit $1tn Valuation
Eli Lilly, the US pharma giant, has become the first drugmaker to hit $1tn valuation on November 22, 2025, hence entering the exclusive club, which is so far dominated by technology giants, highlighting its rise as a weight-loss powerhouse.
The...
Business & Industry
400 Global Regulatory Manufacturing Approvals for Samsung Biologics
Samsung Biologics announced on November 26, 2025, that it has gone on to achieve a whopping 400 regulatory manufacturing approvals all over the world due to its quality competitiveness.
It is worth noting that as of November 2025, Samsung Biologics has secured...
Business & Industry
AstraZeneca, Biopharma Giant, Announces $2bn Investment in Maryland
It should not be termed as an overstatement when we say that Maryland is fast becoming the home away from home when it comes to AstraZeneca, the British drugmaker. On November 21, the biopharma powerhouse pushed it up a...
BioPharma
Australian Biopharma to Expand US Plasma-Derived Therapies
The Australian-based biopharma company, CSL, plans to invest almost $1.5 billion in the next five years so as to expand its presence in the U.S. However, this is going to be subject to the approval from the board of...
Business & Industry
Pfizer to Acquire Metsera in a $10bn Deal as Board Backs
The news of Pfizer to acquire Metsera in a $10bn deal has indeed caught the eye of many. Metsera happens to be a US-based biotechnology firm and the deal was indeed a result of a heated bidding battle against...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















